Tabimorelin (NN-703) is a drug which acts as a potent orally active growth hormone secretagogue mimicking the effects of the endogenous peptide agonist ghrelin as a stimulator of growth hormone release. It was one of the first GH secretagogues developed and is largely a modified polypeptide but it is nevertheless orally active in vivo.
This page contains content from the copyrighted Wikipedia article "Tabimorelin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
